Trials / Completed
CompletedNCT02346890
A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722
A Phase 1, Single-center, Randomized, 2-way Crossover, Open Label Study to Evaluate the Effect of Renvela on the Pharmacodynamics of AZD1722 in Healthy Volunteeers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Ardelyx · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The study is designed to evaluate safety, tolerability, pharmacodynamics and pharmacokinetics of AZD1722 in healthy volunteers taking Renvela.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD1722 | |
| DRUG | Renvela |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2015-01-27
- Last updated
- 2015-01-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02346890. Inclusion in this directory is not an endorsement.